Cerenome (PSTV) Accumulated Expenses (2011 - 2024)
Plus Therapeutics (PSTV) posted quarterly Accumulated Expenses of $117000.0 for Q4 2024, down 88.15% year-over-year from $987000.0 in Q1 2024, and down 88.15% quarter-over-quarter from $987000.0 in Q4 2023.
Cerenome (PSTV) Accumulated Expenses (2011 - 2024) Analysis & Trends
Plus Therapeutics (PSTV) has reported Accumulated Expenses for 14 consecutive years, with $117000.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Accumulated Expenses fell 88.15% year-over-year to $117000.0; the TTM figure through Dec 2024 stood at $117000.0 (down 88.15% YoY), while the FY2024 annual figure was $117000.0, down 88.15% from the prior year.
- Accumulated Expenses retreated to $117000.0 in Q4 2024 per PSTV's latest filing, from $987000.0 in the prior quarter.
- Across five years, Accumulated Expenses topped out at $989000.0 in Q4 2022 and bottomed at $117000.0 in Q4 2024.
- Historically, Accumulated Expenses has averaged $722400.0 across 5 years, with a median of $781000.0 in 2021.
- Annual changes were most pronounced in 2022 — Accumulated Expenses grew 26.63% — and 2024, when it plunged 88.15%.
- Plus Therapeutics' Accumulated Expenses stood at $738000.0 in 2020, then climbed by 5.83% to $781000.0 in 2021, then increased by 26.63% to $989000.0 in 2022, then dropped by 0.2% to $987000.0 in 2023, then slumped by 88.15% to $117000.0 in 2024.
- Business Quant data shows PSTV's Accumulated Expenses at $117000.0 in Q4 2024, $987000.0 in Q4 2023, and $989000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 117,000.00 |
| Dec 31, 2023 | 987,000.00 |
| Dec 31, 2022 | 989,000.00 |
| Dec 31, 2021 | 781,000.00 |
| Dec 31, 2020 | 738,000.00 |
| Dec 31, 2019 | 679,000.00 |
| Dec 31, 2018 | 423,000.00 |
| Dec 31, 2017 | 64,000.00 |
| Dec 31, 2016 | 989,000.00 |
| Dec 31, 2015 | 573,000.00 |
| Dec 31, 2014 | 577,000.00 |
| Dec 31, 2013 | 759,000.00 |
| Dec 31, 2012 | 873,000.00 |
| Dec 31, 2011 | 226,000.00 |